Skip to main content
logo
Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
0.4622
+0.0122 (2.71%)
Aug 3, 2026, 11:39 AM EDT - Market open

Traws Pharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.732.790.230.230.230.23
Revenue Growth
1103.96%1134.51%0%0%0%-2.17%
Gross Profit
2.732.790.230.230.230.23
Operating Income
-19.62-17.88-142.37-20.3-19.63-16.5
Net Income
-14.756.87-54.67-18.95-18.96-16.16
Earnings Per Share
-1.710.82-35.21-22.57-0.91-0.96
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
3.133.8221.3420.8238.760.06
Net Cash Growth
-80.34%-82.10%2.48%-46.28%70277.70%-99.71%
Cash & Investments
3.133.8221.3420.8238.760.06
Net Cash Per Share
0.360.4613.7424.801.850.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-15.32-18.19-29.79-17.93-16.29-19.49
Capital Expenditures
----0.01--
Free Cash Flow
-15.32-18.19-29.79-17.95-16.29-19.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-717.82%-640.68%-62997.30%-8981.42%-8684.51%-7299.12%
Pretax Margin
-710.83%328.67%-73682.74%-8384.07%-8391.15%-7151.77%
Profit Margin
-710.83%328.67%-73682.70%-8384.07%-8391.15%-7151.77%
FCF Margin
-560.70%-651.79%-13182.30%-7940.71%-7209.73%-8622.57%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-1.38----
Forward PE
-8.158.158.158.158.15
PS Ratio
2.584.76259.7269.711504.635894.21